ישראל - עברית - Ministry of Health

j-c health care ltd - estradiol as hemihydrate 1.6 mg - patches - estradiol - deficiency symptoms by absence of estrogen after the menopause or after surgical removal of the ovarians. they comprise hot flushes, insomnia, atrophies of the urogenital system, changes of mood and increasing loss of the bone substance, which can lead to osteoporosis. in women with intact uterus, estrogen substitution must always be supplemented with a sequential gestagen therapy.

ישראל - עברית - Ministry of Health

j-c health care ltd - estradiol as hemihydrate 4.8 mg - patches - estradiol - deficiency symptoms by absence of estrogen after the menopause or after surgical removal of the ovarians. they comprise hot flushes, insomnia, atrophies of the urogenital system, changes of mood and increasing loss of the bone substance, which can lead to osteoporosis.in women with intact uterus, estrogen substitution must always be supplemented with a sequential gestagen therapy.

ישראל - עברית - Ministry of Health

j-c health care ltd - estradiol as hemihydrate 6.4 mg - patches - estradiol - deficiency symptoms by absence of estrogen after the menopause or after surgical removal of the ovarians. they comprise hot flushes, insomnia, atrophies of the urogenital system, changes of mood and increasing loss of the bone substance, which can lead to osteoporosis. in women with intact uterus, estrogen substitution must always be supplemented with a sequential gestagen therapy.

ישראל - עברית - Ministry of Health

merck sharp & dohme israel ltd - human chorionic gonadotropin - אבקה להכנת תמיסה לזריקה - human chorionic gonadotropin 5000 iu/ml - chorionic gonadotrophin - chorionic gonadotrophin - in the female: ovulation induction in infertility due to anovulation or impaired follicle-ripening. preparation of follicles for puncture in controlled ovarian hyperstimulation programs. luteal phase support. in the male: hypogonadotropic hypogonadism (also cases of idiopathic dysspermias have shown a positive response to gonadotropins). delayed puberty associated with insufficient gonadotropic pituitary function.cryptorchidism not due to anatomical obstruction.

ישראל - עברית - Ministry of Health

ferring pharmaceuticals ltd - menotrophin - אבקה וממס להכנת תמיסה להזרקה - menotrophin 600 iu - human menopausal gonadotrophin - human menopausal gonadotrophin - sterility in females with hypo or normogonadotropic ovarian insufficiency : stimulation of follicle growth. sterility in males with hypo or normogonadotropic hypogonadism: in combination with hcg to spermatogenesis.

ישראל - עברית - Ministry of Health

ferring pharmaceuticals ltd - menotrophin - אבקה וממס להכנת תמיסה להזרקה - menotrophin 1200 iu - human menopausal gonadotrophin - human menopausal gonadotrophin - sterility in females with hypo or normogonadotropic ovarian insufficiency: stimulation of follicle growth. sterility in males with hypo or normogonadotropic hypogonadism: in combination with hcg to spermatogenesis

ישראל - עברית - Ministry of Health

tzamal bio-pharma ltd - urofollitropin - אבקה להכנת תמיסה לזריקה - urofollitropin 75 iu/vial - urofollitropin - urofollitropin - a treatment with fsh followed by the administration of human chronic gonadotrophin (hcg) is indicated to induce ovulation in infertile women suffering from hypothalamus or hypophyseal disorders and in spanomenorrhoeic or amenorrhoeic women. these women belong to the who group ii and have generally already been treated with clomiphene citrate. most have polycystic ovarian syndrome. fsh offers good therapeutic prospects for patients whose lh:fsh ratio has to be adjusted, avoiding an exogenous supply of lh fsh may be used alone or in concomitance with human menopausal gonadotropin (hmg) in order to stimulate multiple follicular growth in patients involved in medically assisted reproduction programs (ivf-et,gift).

ישראל - עברית - Ministry of Health

tzamal bio-pharma ltd - urofollitropin - אבקה להכנת תמיסה לזריקה - urofollitropin 150 iu/vial - urofollitropin - urofollitropin - a treatment with fsh followed by the administration of human chronic gonadotrophin (hcg) is indicated to induce ovulation in infertile women suffering from hypothalamus or hypophyseal disorders and in spanomenorrhoeic or amenorrhoeic women. these women belong to the who group ii and have generally already been treated with clomiphene citrate. most have polycystic ovarian syndrome. fsh offers good therapeutic prospects for patients whose lh:fsh ratio has to be adjusted, avoiding an exogenous supply of lh fsh may be used alone or in concomitance with human menopausal gonadotropin (hmg) in order to stimulate multiple follicular growth in patients involved in medically assisted reproduction programs (ivf-et,gift).

ישראל - עברית - Ministry of Health

merck serono ltd - follitropin alfa - אבקה להכנת תמיסה לזריקה - follitropin alfa 5.5 mcg/dose - follitropin alfa - follitropin alfa - 1) gonal-f followed by chorionic gonadotrophin (hcg) is recommended for the stimulation of follicular development and ovulation in women with hypothalamic-pituitary dysfunction who present with either oligomenorrhoea or amenorrhoea. these women are classified as w.h.o group ii patients and usually receive clomiphene citrate as primary therapy. they have evidence of endogenous oestrogen production and thus will either spontaneously menstruate or experience withdrawal bleeding after progestagen administration. polycystic ovarian disease (pcod) is part of the who ii classification and is present in the majority of these patients. 2) gonal-f is indicated for stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertillization (ivf) gamete intra-fallopian transfer (gift) and zogote intra-fallopian transfer (zift). 3) gonal-f is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of sperma

ישראל - עברית - Ministry of Health

organon pharma israel ltd., israel - corifollitropin alfa - תמיסה להזרקה - corifollitropin alfa 100 mcg / 0.5 ml - corifollitropin alfa - corifollitropin alfa - controlled ovarian stimulation (cos) in combination with a gnrh antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (art) program.